348 related articles for article (PubMed ID: 29661411)
41. Minimum false-positive risk of primary outcomes and impact of reducing nominal P-value threshold from 0.05 to 0.005 in anaesthesiology randomised clinical trials: a cross-sectional study.
Chuang Z; Martin J; Shapiro J; Nguyen D; Neocleous P; Jones PM
Br J Anaesth; 2023 Apr; 130(4):412-420. PubMed ID: 36503825
[TBL] [Abstract][Full Text] [Related]
42. Statistical fragility of randomized clinical trials in shoulder arthroplasty.
McCormick KL; Tedesco LJ; Swindell HW; Forrester LA; Jobin CM; Levine WN
J Shoulder Elbow Surg; 2021 Aug; 30(8):1787-1793. PubMed ID: 33271323
[TBL] [Abstract][Full Text] [Related]
43. Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up.
Greenfield ML; Mhyre JM; Mashour GA; Blum JM; Yen EC; Rosenberg AL
Anesth Analg; 2009 Jun; 108(6):1916-21. PubMed ID: 19448222
[TBL] [Abstract][Full Text] [Related]
44. Fragility Index in Randomized Controlled Trials of Ischemic Stroke.
Sato K; Toda T; Iwata A
J Stroke Cerebrovasc Dis; 2019 May; 28(5):1290-1294. PubMed ID: 30765294
[TBL] [Abstract][Full Text] [Related]
45. The fragility of statistically significant results in otolaryngology randomized trials.
Skinner M; Tritz D; Farahani C; Ross A; Hamilton T; Vassar M
Am J Otolaryngol; 2019; 40(1):61-66. PubMed ID: 30472124
[TBL] [Abstract][Full Text] [Related]
46. Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
Huang X; Chen B; Thabane L; Adachi JD; Li G
Osteoporos Int; 2021 Sep; 32(9):1713-1723. PubMed ID: 33595680
[TBL] [Abstract][Full Text] [Related]
47. Risk of bias assessment of randomised controlled trials in high-impact ophthalmology journals and general medical journals: a systematic review.
Joksimovic L; Koucheki R; Popovic M; Ahmed Y; Schlenker MB; Ahmed IIK
Br J Ophthalmol; 2017 Oct; 101(10):1309-1314. PubMed ID: 28659390
[TBL] [Abstract][Full Text] [Related]
48. Pitfalls in reporting sample size calculation in randomized controlled trials published in leading anaesthesia journals: a systematic review.
Abdulatif M; Mukhtar A; Obayah G
Br J Anaesth; 2015 Nov; 115(5):699-707. PubMed ID: 26041717
[TBL] [Abstract][Full Text] [Related]
49. Reporting quality of randomised controlled trial abstracts among high-impact general medical journals: a review and analysis.
Hays M; Andrews M; Wilson R; Callender D; O'Malley PG; Douglas K
BMJ Open; 2016 Jul; 6(7):e011082. PubMed ID: 27470506
[TBL] [Abstract][Full Text] [Related]
50. The Fragility of Statistically Significant Findings in Pediatric Critical Care Randomized Controlled Trials.
Matics TJ; Khan N; Jani P; Kane JM
Pediatr Crit Care Med; 2019 Jun; 20(6):e258-e262. PubMed ID: 31013262
[TBL] [Abstract][Full Text] [Related]
51. Reporting quality of randomized controlled trial abstracts in the seven highest-ranking anesthesiology journals.
Janackovic K; Puljak L
Trials; 2018 Oct; 19(1):591. PubMed ID: 30373644
[TBL] [Abstract][Full Text] [Related]
52. The Fragility Index of Hip Arthroscopy Randomized Controlled Trials: A Systematic Survey.
Maldonado DR; Go CC; Huang BH; Domb BG
Arthroscopy; 2021 Jun; 37(6):1983-1989. PubMed ID: 33539980
[TBL] [Abstract][Full Text] [Related]
53. Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours.
Desnoyers A; Wilson BE; Nadler MB; Amir E
Cancer Treat Rev; 2021 Mar; 94():102167. PubMed ID: 33652263
[TBL] [Abstract][Full Text] [Related]
54. Calculation of the fragility index of randomized controlled trials in epilepsy published in twelve major journals.
Das S; Xaviar S
Epilepsy Res; 2020 Jan; 159():106258. PubMed ID: 31869724
[TBL] [Abstract][Full Text] [Related]
55. The Fragility of Statistically Significant Findings From Randomized Controlled Trials in Hip and Knee Arthroplasty.
Ekhtiari S; Gazendam AM; Nucci NW; Kruse CC; Bhandari M
J Arthroplasty; 2021 Jun; 36(6):2211-2218.e1. PubMed ID: 33390336
[TBL] [Abstract][Full Text] [Related]
56. Thresholds for interpreting the fragility index derived from sample of randomised controlled trials in cardiology: a meta-epidemiologic study.
Murad MH; Kara Balla A; Khan MS; Shaikh A; Saadi S; Wang Z
BMJ Evid Based Med; 2023 Apr; 28(2):133-136. PubMed ID: 35264405
[TBL] [Abstract][Full Text] [Related]
57. The Fragility of Statistically Significant Findings From Randomized Trials in Sports Surgery: A Systematic Survey.
Khan M; Evaniew N; Gichuru M; Habib A; Ayeni OR; Bedi A; Walsh M; Devereaux PJ; Bhandari M
Am J Sports Med; 2017 Jul; 45(9):2164-2170. PubMed ID: 27895038
[TBL] [Abstract][Full Text] [Related]
58. Urologic oncology randomized controlled trials are frequently fragile - A review of the urology literature.
Chertin L; Burman I; Haifler M
Urol Oncol; 2021 Oct; 39(10):735.e1-735.e8. PubMed ID: 34103225
[TBL] [Abstract][Full Text] [Related]
59. Statistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals.
McClean M; Silverberg JI
Br J Dermatol; 2015 Jul; 173(1):172-83. PubMed ID: 25989239
[TBL] [Abstract][Full Text] [Related]
60. The fragility of statistical significance in distal femur fractures: systematic review of randomized controlled trials.
Megafu M; Mian H; Megafu E; Singhal S; Lee A; Cassie R; Tornetta P; Parisien R
Eur J Orthop Surg Traumatol; 2023 Aug; 33(6):2411-2418. PubMed ID: 36461949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
